Previous Article | Next Article ![]()
Eukaryotic Cell, July 2006, p. 1136-1146, Vol. 5, No. 7
1535-9778/06/$08.00+0 doi:10.1128/EC.00383-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461
Received 23 December 2005/ Accepted 26 April 2006
|
|
|---|
|
|
|---|
8 h. Responses known to be
activated by binding of extracellular cAMP to the plasma membrane cAMP
receptor (cAR1) include activation of adenylyl cyclase A (ACA) and
guanylyl cyclase, production of phosphatidylinositol phosphates,
synthesis of intracellular cAMP and relay of the extracellular cAMP
signals, chemotaxis, and expression of development stage
genes. Mitogen-activated protein (MAP) kinase cascades are conserved signaling pathways in eukaryotes for the transfer of extracellular signals to a variety of intracellular regulatory pathways. These sequentially activated kinase cascades are induced by diverse G protein- and tyrosine kinase-coupled receptors. In Dictyostelium cells, three components of MAP kinase cascades have been identified. The MAP kinase kinase (MEK) DdMEK1 is required for chemotaxis toward cAMP during aggregation (13). Knockout of DdMEK1 impaired the formation of normal-sized aggregates. However, these small aggregates can still differentiate to form normally proportioned, small fruiting bodies. DdMEK1 is required for activation of guanylyl cyclase and the synthesis of cGMP, a second messenger regulating chemotaxis, in response to extracellular cAMP. There are two MAP kinases, DdERK1 and DdERK2, in Dictyostelium cells. Their activity peaks between 15 s and 1 min after stimulation (26, 32). In general, ERKs are proline directed in that they target substrates that contain a proline in the P+1 site (Ser/Thr-Pro) (23). ERKs are uniformly distributed in the cytoplasm in quiescent cells, but a significant population of ERKs accumulates in the nucleus upon stimulation. Activated ERKs phosphorylate numerous substrates in all cellular compartments, including various nuclear substrates (SRC-1, Pax6, NF-AT, Elk-1, MEF2, c-Fos, c-Myc, and STAT3), membrane proteins (CD120a, Syk, and calnexin), cytoskeletal proteins (neurofilaments and paxillin), and several protein kinases (RSK, MSK, and MNK) (20).
We and others have previously found that DdERK2 contributes to Dictyostelium chemotaxis (14, 15, 26, 34). Dderk2 cells show defects in folate and cAMP chemotaxis and fail to accumulate intracellular cAMP. Identification of a substrate(s) of DdERK2 will enhance our understanding of how DdERK2 regulates chemotaxis. In this study, we identified a new substrate of DdERK2, EppA. DdERK2 regulates phosphorylation of EppA at serine 250, and DdERK2-dependent phosphorylation of EppA is important in regulating directionality, velocity, and persistence during chemotaxis to cAMP. EppA is also required for accumulation of intracellular cAMP.
|
|
|---|
2-D electrophoresis. For isoelectric focusing (IEF), 18-cm precast IPG strips (pI 4 to 7) and an IPGphor IEF unit (Amersham Pharmacia Bioscience, Sunnyvale, CA) were used as described elsewhere (8). Three hundred micrograms of protein was focused for 98,000 Vh in a sample buffer containing 6 M urea, 2 M thiourea, 4% 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS), 0.5% Pharmalyte (pH 3 to 10), 0.5% Pharmalyte (pH 4 to 7), and 0.4% dithiothreitol. As soon as IEF was finished, the strips were either frozen at 70°C or equilibrated with buffer (0.375 M Tris-Cl [pH 8.8], 6 M urea, 1% sodium dodecyl sulfate [SDS], and 30% glycerol) containing 1% dithiothreitol or 4% iodoacetamide for 10 min each. Then the second dimension was carried out on 10% SDS-acrylamide gels. After electrophoresis, radioactive 2-dimensional (2-D) gels were stained with colloidal Coomassie brilliant blue (Sigma; 0.5% in 50% methanol-10% acetic acid), wrapped in plastic film, exposed for 1 to 3 days to PhosphorImager screens (Molecular Dynamics, Sunnyvale, CA), and scanned with a Storm 4500 imager(Molecular Dynamics) at a resolution of 100 pixels/cm and a depth of 8 bits. Radioactively labeled filter squares were placed at the corners of the gels for alignment with corresponding Coomassie-stained images using Adobe Photoshop, version 5.5.
MS analysis of protein.
Excised protein spots were destained
and digested as described elsewhere
(http://donatello.ucsf.edu/ingel.html).
The digested peptides were concentrated with C18 Ziptips
(Millipore, Billerica, MA) and placed on matrix-assisted laser
desorption ionization (MALDI) target plates with
-cyano-4-hydroxycinnamic acid in 50% acetonitrile-1%
trifluoroacetic acid. MALDI-time-of-flight (TOF) mass
spectrometry (MS) was performed using a Voyager mass spectrometer
(Applied Biosystems, Foster City, CA). MS spectra were interpreted
using the Data Explore program, version 4.0. Samples from four gels
were pooled and submitted to the Rockefeller University Proteomics
Resource Center for liquid chromatography-tandem MS (LC-MS/MS)
identification. Sequences collected from tryptic peptides were used to
search the Dictyostelium genomic sequence
database.
Expression constructs of myc-tagged EppA protein and point mutations of serine residues in myc-EppA. All DNA manipulations were carried out according to standard molecular biology techniques (21). All restriction enzymes were from Promega. The D. discoideum genome and cDNA database were searched using amino acid sequences acquired from LC-MS/MS, and as a result, a genomic DNA sequence was found on chromosome 4. Full-length cDNA (clone VFD141) was provided by the Japanese Dictyostelium cDNA project, and primers were designed for adding a single myc tag to the full-length cDNA. PCR amplification was performed with primers EppA-5'-myc (5'-GCATGCctgagcaaaagttaatctccgaagaggaccttatttcaaataagaccaaattcaat-3']; the myc coding sequence is underlined) and EppA-3' (5'-GAGCTCttaaattgatttagttttgttgat-3'), carrying SphI and SacI restriction enzyme sites (capitalized and italicized), respectively. All PCR amplifications were carried out using the Pfx high-fidelity PCR system. The PCR product thus amplified was purified using a QIAquick PCR purification kit (QIAGEN, Valencia, CA), cloned into the pGEM-T plasmid vector (Promega), and sequenced. Then the SphI-SacI fragment was inserted into the pDNeo II plasmid to create a pDNeo II-EppA plasmid vector in which EppA carries an N-terminal myc tag. The insertion was confirmed by sequencing.
To generate point mutations of serine residues in EppA, the pDNeo II-EppA vector was used as a template, and four pairs of primers (S64A [5'-TCATCATCATCCTCCGCACCACAAGAAAAGAAA-3'and 5'-TTTCTTTTCTTGTGGTGCGGAGGATGATGATGA-3'], S126A [5'-CAAAGAGGTGAAGATGCACCATCTGAAAGAGAT-3'and 5'-ATCTCTTTCAGATGGTGCATCTTCACCTCTTTG-3'], S250A [5'-TTCAGCAATGGTGTTGCCCCATTCAACTTCAAG-3'and 5'-CTTGAAGTTGAATGGGGCAACACCATTGCTGAA-3'], and S325A [5'-AATCCATTCGGTGGTGCCCCAAGAAACTAC-3'and 5'-ATCGTAGTTTCTTGGGGCACCACCGAATGGATT-3']; mutations are underlined) were designed to change serine to alanine using the QuikChange kit (Stratagene, La Jolla, CA) by following the manufacturer's instructions. The DpnI-digested PCR product was used to transform Escherichia coli HB101 cells. Plasmids carrying the correct point mutation were confirmed by sequencing.
Generation of stable cell lines. Stable Dictyostelium cell lines expressing myc-tagged EppA proteins were generated as described previously (19) with the following modifications. HS176 and HS174 cells growing in suspension were collected and electroporated in H-50 buffer by using 10 µg of the above-mentioned plasmid expression vector DNA, and after overnight growth in growth medium, transformants were selected in the presence of 10 µg/ml G418. Individual colonies were picked after 7 to 10 days and then transferred to 24-well plates, followed by further growth in 10-cm culture plates. Total-cell lysates made from each putative clone were tested for the expression of myc-tagged EppA proteins by performing Western blot analyses with an anti-myc antibody (Upstate, Charlottesville, VA).
Immunoprecipitation and Western blotting.
HS176 and HS174
stable cell lines expressing myc-tagged EppA protein were grown in
suspension. The protocol described above was used for starvation and
stimulation. For each sample, 200 µl of cells was lysed in 200
µl of 2x radioimmunoprecipitation assay buffer
(35) and vortexed for
5 s. The supernatant obtained by centrifugation at high speed
in a cold room centrifuge (10 min in a Microfuge at
10,000 x g) was mixed with anti-myc
immunoglobulin G (BioMol, Plymouth Meeting, PA) and kept on a rotating
shaker for 1 h at 4°C. Protein G-agarose beads
(Upstate) were added, and the sample was kept on the rotating shaker
for 1 h at 4°C. Then beads were collected by
centrifugation at high speed for 10 s. The protein-bound
beads were subjected to thorough washing with ice-cold
radioimmunoprecipitation assay buffer. After removal of excess washing
buffer, protein beads were resuspended in 80 µl 2x SDS
sample buffer and boiled for 5 min.
Western blot analyses were performed as described previously (35) with the following modifications. Cells (1 x 107) in MES buffer were lysed by an equal volume of 2 x SDS sample buffer carrying 1 mM 2-mercaptoethanol and then boiled at 95°C for 5 min. Lysate samples (10 µl) or immunoprecipitation products (20 µl) were subjected to electrophoresis on 10% SDS-acrylamide gels and then transferred to nitrocellulose membranes using a Trans-Blot SD semidry transfer cell (Bio-Rad, Hercules, CA) and probed with corresponding antibodies. The anti-ERK2 antibody was made against the Dictyostelium protein DdERK2 and detects both unphosphorylated and phosphorylated forms (35). The anti-cAR1 antibody is a gift from P. Devreotes. Signal was detected with corresponding horseradish peroxidase-linked secondary antibodies (Pierce, Rockford, IL) by the PicoWest reagents (Pierce) and chemiluminescence detection system.
Gene disruption in Dictyostelium.
The disruption construct was
assembled in plasmid pBsr
BglII. A 440-bp DNA sequence was PCR
amplified using primer 1
(5'-TCTAGAaccacgttcatcctattcag-3')
and primer 2
(5'-ACTAGTacgattaccaccataaccac-3')
from the N terminus of the eppA gene. (The capitalized and
italicized bases correspond to XbaI and SpeI restriction sites,
respectively.) The purified DNA fragment was cloned as an XbaI/SpeI
fragment into the XbaI site of pBsr
BglII to generate the
pBsr
BglII-5'-EppA vector. Similarly, another DNA
fragment of 626 bp was PCR amplified using primer 3
(5'-AAGCTTACTAGTtcatgttgttcgttgttgtca-3')
with HindIII and SpeI sites and primer 4
(5'-AAGCTTtggctatggtggtaatcgtga-3')
with the HindIII site from the C terminus of the eppA gene.
The purified fragment was digested with HindIII and cloned into the
HindIII site of the pBsr
BglII-5'-EppA vector to create
the pBsr
BglII-EppA-KO plasmid vector. The SpeI site in primer
3 was used to determine the orientation of the insertion. From this
vector DNA, the entire knockout cassette carrying the blasticidin
resistance cartridge in the middle was PCR amplified using primers 1
and 4. The amplified PCR DNA was purified and used for electroporation
of HS176 cells as described previously
(2). Transformants were
selected in the presence of 10 µg/ml blasticidin in the growth
medium. Individual clones were isolated, amplified, and
subjected to further analyses. Genomic DNA isolated from each clone was
analyzed by genomic PCR by using primers 1 and
4.
Chemotaxis of Dictyostelium cells in a Zigmond chamber. Cells were starved with pulsing as described above for 8 h. cAMP chemotaxis was assayed as described previously (24). In brief, after starvation for 8 h, cells were diluted to 2 x 105/ml in Ca/Mg phosphate buffer and separated by shearing 20 times with a 200-ml Gilson Pipetman. The cells were then allowed to settle onto an acid-cleaned coverslip for 15 min, and the coverslip was placed on a Zigmond chamber (Neuroprobe, Gaithersburg, MD). The cells were initially followed in the absence of a gradient; then, after 15 to 20 min, a gradient was imposed. Ten minutes after the cAMP gradient was established, cell motility parameters were followed at 10-min intervals for 20 to 30 min. Cell behavior was analyzed with ImageJ. Cell position was measured every 30 s. Theta is defined as the angle between the cAMP gradient and the line connecting the starting and ending centroids every 30 s. The instantaneous velocity is the difference in position between cell centroids in two consecutive frames divided by 30 s. Persistence was calculated by dividing the distance by the path length, where the distance is the difference between the starting centroid and the centroid at 10 min, and the path length is the sum of all centroid differences measured in 30-s intervals. The average for each cell was in further statistical analyses.
In vivo cAMP production assays. Cells were starved 2 h in phosphate buffer, pulsed for 4 h, treated with 2.5 mM caffeine for 30 min, washed twice, resuspended in Ca/Mg phosphate buffer to 5 x 107/ml, and incubated for 5 min at room temperature. Then the cells were stimulated with 10 µM 3'-deoxy-cAMP(Sigma). Aliquots of stimulated cells were taken at specific time points, lysed by an equal volume of 3.5% perchloric acid, and neutralized by 50% saturated potassium bicarbonate. The total level of cAMP was measured by a competition assay using an Amersham TRK 432 kit.
Folate chemotaxis assays. Axenically grown cells were centrifuged and cells from the pellet dotted on an agar dish containing 1% Bacto agar (Difco, Sparks, MD) in 17 mM phosphate buffer, 1 mM MgCl2, and 1 mM CaCl2. They were placed 3 to 4 mm from the edge of a well containing 1 mM folate. The positions of the cells were recorded by photographing at the beginning and after 7 to 9 h. The distance of the moving front was measured and used to calculate an average speed of spread. Then the average speeds were converted to the percentage of the speed of wild-type cells. Results are means ± standard errors of the means from three experiments.
Reverse transcription-PCR (RT-PCR) analysis of eppA expression. At different time points during the development at 22°C, total RNA was isolated from HS176 cells by using TRIzol reagent, followed by synthesis of cDNA with random hexamers as primers. Using synthesized cDNA as a template, PCR amplifications were performed with eppA gene-specific primers eppA(361-382) (5'-GGTAATGCTAGACCAACTGATG-3') and eppA(889-865) (5'-CACGATCTTGAGTACCTCTGTAACC-3') to amplify a 528-bp fragment. As a control, the constitutively expressed gene IG7 (18) was amplified with primer pairs IG7-S (5'-TTACATTTATTAGACCCGAAACCAAGCG-3') and IG7-AS (5'-TTCCCTTTAGACCTATGGACCTTAGCG-3') on the same template sample.
|
|
|---|
![]() View larger version (77K): [in a new window] |
FIG.1. Identification
of EppA by 2-D electrophoresis of 32P-labeled cells.
(A) Coomassie brilliant blue-stained 2-D gels of wild-type
and Dderk2 cells before and 1 min after
stimulation with cAMP. The box in the wild-type 1-min sample is shown
at higher magnification in panel C. Black squares in diagonally
opposite corners are filter papers containing 32P for
registration of the autoradiograms in panel B. (B)
Autoradiography of 2-D gels in panel A. Phosphoproteins present in
three experiments and quantitated in Table
1 are labeled in the
autoradiogram of the stimulated wild-type sample. (C)
DdERK2-dependent protein position shift and phosphorylation change of
EppA. The arrowhead points to the position of phosphorylated EppA (spot
3 in Fig. 1B), and arrows
indicate the corresponding position in samples from unstimulated or
DdErk2 cells.
|
|
View this table: [in a new window] |
TABLE 1. Comparison of protein phosphorylation changes
|
Identification of EppA. To identify the potential DdERK2 substrate EppA, the protein was excised from the Coomassie brilliant blue-stained gels and digested with trypsin, and the peptides extracted from the digestion were used for MS/MS sequencing and MALDI-TOF analysis. Upon a search of the Dictyostelium genomic database with the MS/MS sequencing results (Table 2), sequence matches with a single 45-kDa open reading frame in expressed sequence tag and genomic databases (7, 17) were identified with high probability. The MALDI-MS spectrum covered 34.6% of the open reading frame, confirming the MS/MS sequencing identification (Fig. 2). The eppA gene (DDB0218473) is located on chromosome 4 with one intron. We have not yet found a homologue of EppA in other species. There are four potential ERK phosphorylation sites (Ser/Pro) in the protein (Fig. 2B) and possible evidence for a phosphopeptide containing serine 250 (shown in Fig. 2C).
|
View this table: [in a new window] |
TABLE 2. Peptides
from EppA sequenced by tandem MS/MS
|
![]() View larger version (29K): [in a new window] |
FIG.2. Identification
of EppA by mass spectrometry. (A) MALDI-TOF spectrum of EppA
protein. The spot corresponding to phosphorylated EppA was excised and
digested with trypsin. The tryptic peptides were extracted and
subjected to MALDI-TOF analysis. Peaks that match theoretical tryptic
digested peptide masses from EppA are marked by asterisks.
(B) Amino acid sequence of EppA. The amino acid sequence was
derived from full-length cDNA sequences (clone sVFD141 and AFK 496)
provided by the Japanese Dictyostelium cDNA project. Four
potential Erk2 phosphorylation sites (Ser/Pro) are labeled with
asterisks. Amino acids sequenced by LC-MS/MS are boldfaced, and
sequences covered by MALDI-TOF are underlined. (C) Mass
spectrum of potential phosphopeptide. A portion of panel 2A was
enlarged to show a peak (1,244.45 Da) (left arrow) potentially
representing the peptide containing serine 250 (amino acids 245 to 255)
and the peak (1,323.42 Da) (right arrow) potentially representing the
phosphorylated peptide.
|
![]() View larger version (24K): [in a new window] |
FIG. 3. ERK2-mediated
phosphorylation of EppA. (A) myc-tagged EppA construct and
putative phosphorylation sites that were mutated. (B)
ERK2-dependent in vivo phosphorylation of myc-EppA. (Upper panel)
myc-EppA was immunoprecipitated from lysates of 32P-labeled
wild-type (wt) or Dderk2
(erk2) Dictyostelium cells stably
expressing myc-EppA before and after stimulation with 10 µM
cAMP. Immunoprecipitates (IP) were separated by SDS-polyacrylamide gel
electrophoresis and stained with Coomassie brilliant blue, and
phosphorylation was quantitated by a PhosphorImager. (Lower panel)
Control to confirm that the lower band is myc-EppA. IgG, immunoglobulin
G. (C) Time course of cAMP-induced EppA phosphorylation.
Wild-type and Dderk2 cells overexpressing
myc-tagged EppA were starved 6 h and labeled with
32PO43. myc-tagged EppA was
immunoprecipitated from lysates prepared at different time points after
cAMP stimulation. The phosphorylation level at each time point was
standardized by the amount of myc-EppA. Phosphorylation of DdERK2 after
cAMP stimulation was detected by Western blotting, and the densities of
corresponding bands were measured and used to determine the percentage
of DdERK2 phosphorylated. Values are averages from two experiments.
Error bars indicate the range of the original data. (D)
Identification of phosphorylation sites. Cells stably expressing
myc-EppA constructs carrying the single point mutations identified in
panel A were labeled and stimulated, and the myc-tagged protein was
immunoprecipitated for SDS-polyacrylamide gel electrophoretic analysis
as for panel B. The 32P signal was normalized to myc-EppA
protein staining, and the relative change in EppA phosphorylation
(32P density of stimulated sample/density of unstimulated
sample) was averaged from three to four
experiments.
|
Expression of eppA was also assessed. RT-PCR of a 528-bp fragment of the eppA cDNA from total RNA indicated that on the mRNA level there is little alteration during development (Fig. 4A). eppA mRNA expression levels were similar in Dderk2 mutants (data not shown).
![]() View larger version (75K): [in a new window] |
FIG. 4. Disruption
of the eppA gene and evaluation of development and growth of
Dictyostelium cells. (A) Expression of the
eppA gene during development. Wild-type cells (HS176) growing
in suspension culture were collected by centrifugation, followed by a
wash with phosphate buffer. The cell pellet was resuspended
in the buffer, and 1 x 107 cells (in 1 ml buffer)
were placed on top of Ca/Mg-phosphate agar plates. RNA was isolated at
the indicated times. RT-PCR was performed with eppA-specific
primers after generation of first-strand cDNA by reverse transcriptase.
PCR mixtures were subjected to electrophoresis on a 1% agarose gel. As
mentioned in Materials and Methods, IG7 is a control constitutively
expressed gene. com is an eppA disruptant
completed by myc-EppA. (B) EppA is required for normal
Dictyostelium development. A total of 106 cells in
100 µl of phosphate buffer were placed on phosphate agar
plates, and cells were allowed to develop at 22°C in a moist
chamber. Pictures were taken at the indicated times. Bar, 1 mm. wt,
wild-type parental cells; eppA, cells with
the eppA gene disrupted by targeting construct; wt/myc-EppA,
wild-type cells overexpressing myc-EppA; wt/myc-EppA(S250A), wild-type
cells overexpressing myc-EppA carrying the S250A point mutation;
eppA/myc-EppA, eppA knockout
cells expressing myc-EppA. (C) Effect of EppA on
Dictyostelium cell growth. Cells were grown in suspension, and
the doubling time was calculated from cell density measurements made
during the exponential-growth phase. Results are means ±
standard errors of the means from three experiments. (D)
Expression of cAR1 in early development of Dictyostelium.
Cells were starved in PB and pulsed with 100 nM cAMP for varying times
after 2 h of starvation. Aliquots of cells were taken at
different time points, lysed by 2x SDS sample buffer, and
Western blotted (WB) with an anti-cAR1 antibody. (E)
cAMP-dependent activation of DdERK2. Cells were starved and pulsed for
7 h, treated with caffeine for 10 min, stimulated with 10
µM cAMP, lysed by an equal volume of 2x SDS sample
buffer at 0 and 30 s after stimulation, and Western blotted
with an anti-DdERK2 antibody. After stimulation, a higher-mobility band
indicates the activated DdERK2 protein under these gel electrophoresis
conditions.
|
eppA disruption also had an effect on cell growth. Wild-type cells divided every 13 h, an interval similar to the 12-h doubling time of the Ax-2 cell line, widely used in Dictyostelium studies (Fig. 4C). However, eppA-disrupted cells grew significantly more slowly, with a doubling time of 21 h. Reintroduction of myc-EppA into eppA cells restored the normal growth rate, with a doubling time of 13.8 h. Mutation of serine 250 or serine 325 also had severe effects on cell growth and increased doubling times to 21 and 27 h, respectively.
EppA is involved in regulation of Dictyostelium chemotaxis. To determine the function of EppA in Dictyostelium chemotaxis, we analyzed responses of wild-type, EppA-overexpressing, and eppA cells to an exogenous cAMP gradient. Disruption of the eppA gene led to significant decreases in both velocity and chemotaxis (Table 3). These cells also made turns more frequently than wild-type cells (reduced persistence). Introduction of myc-tagged EppA protein into eppA cells restored velocity, persistence, and directionality in chemotaxis to cAMP to levels comparable to those of wild-type cells. Expression of EppA in wild-type cells had no significant effect on cell velocity or chemotaxis in a cAMP gradient (Table 3), but expression of the S250A mutant in wild-type cells also significantly reduced the directionality of cells in the cAMP gradient, with moderate inhibition of velocity and persistence (Table 3). These results suggest that EppA is important in regulating Dictyostelium chemotaxis and that ERK2-mediated phosphorylation of serine 250 is required for appropriate chemotaxis.
|
View this table: [in a new window] |
TABLE 3. Quantitation
of cAMP
chemotaxisa
|
![]() View larger version (10K): [in a new window] |
FIG. 5. Quantitation
of folate chemotaxis. As many as 106 cells were placed on an
agar surface 3 to 4 mm away from a well containing 1 mM folate, and the
migration rate measured as described in Materials and Methods. Data are
means and standard errors from three experiments.
|
![]() View larger version (22K): [in a new window] |
FIG. 6. EppA
regulates intracellular cAMP accumulation. Aliquots of cells were lysed
at different times before and after stimulation with 5 µM
2'-deoxy-cAMP, and intracellular cAMP concentrations were
measured. Data are means and standard errors from three or four
experiments.
|
|
|
|---|
For aggregation-stage Dictyostelium cells, binding of cAMP to the plasma membrane receptor cAR1 triggers a series of downstream events involving DdERK2. DdERK2 is activated by stimulation of cells with cAMP, and its kinase activity peaks between 30 s and 1 min after cAMP binding to the receptor. DdERK2 is important for accumulation of intracellular cAMP. Two minutes after binding of cAMP to the receptor cAR1, DdERK2 activity begins to drop; it returns to basal levels after 5 min. Before the identification of EppA, the only ERK2 substrate in Dictyostelium that had been proposed was RegA, a phosphodiesterase that degrades cAMP specifically (27, 28, 31). It has been proposed that upon stimulation of cells with cAMP, inhibition of RegA activity results in increased intracellular cAMP levels (16). Cells with a disruption of regA accumulated more cAMP than wild-type Dictyostelium cells in response to cAMP stimulation. regA disruptants suppress the defect in aggregation and cAMP production of Dderk2 mutants, and control of RegA activity may be due to DdERK2-dependent phosphorylation (16). There are four potential DdERK2 recognition sites in RegA, including threonine 676. Expression of RegA protein carrying a mutation of threonine 676 blocks the stimulated production of intracellular cAMP (16). Although threonine 676 is important for the regulation of RegA, there is no direct evidence of phosphorylation of RegA at threonine 676.
We describe here the identification and characterization of EppA as a novel substrate of DdERK2, which regulates chemotaxis and development of Dictyostelium cells. cAMP-induced and DdERK2-dependent phosphorylation of EppA was first found by comparing 2-D gels of wild-type and Dderk2 samples. MS/MS analysis of the protein excised from 2-D gels provided sequences of nine peptides, which covered 29.6% of the EppA coding sequence. Ten peaks in the MALDI-TOF spectrum of tryptic peptides from EppA matched theoretical digestion of the protein and showed a good coverage of EppA. Immunoprecipitation of myc-tagged EppA from wild-type cells displayed a threefold increase in EppA phosphorylation after cAMP stimulation, while Dderk2 cells showed only a slight increase, confirming that EppA is phosphorylated by a DdERK2-dependent pathway. Disruption of the eppA gene decreased the growth rate and caused delayed development of Dictyostelium cells, and the disruptants formed smaller fruiting bodies. The disruptants showed significantly reduced cAMP-stimulated cAMP production, which could delay aggregation kinetics. In addition, in the Zigmond chamber assay, eppA cells showed a significant decrease in directionality in a cAMP gradient. Cell velocity and persistence also dropped significantly. The combination of reduced cAMP production and reduced chemotactic response is consistent with the delayed aggregation that is observed. DdERK2 was properly activated by cAMP stimulation in eppA cells, indicating that the disruptants were able to develop to the aggregation-competent state and that the major function of EppA is downstream of DdERK2. In addition to chemotaxis to cAMP, EppA disruptants were defective in folate chemotaxis, implying that EppA is required for both cAMP and folate chemotaxis, within the qualitative resolution of the folate chemotaxis assay that was used.
EppA has four potential DdERK2 phosphorylation sites. Mutation of serine 250 to alanine impaired DdERK2-dependent phosphorylation of EppA in response to cAMP stimulation, indicating that serine 250 is required for DdERK2-dependent phosphorylation of EppA. We did not detect DdERK2 coimmunoprecipitated with myc-EppA, implying that DdERK2 interactions with EppA must be relatively brief. Alternatively, it is possible that phosphorylation of EppA at serine 250 is performed by another kinase that is in turn activated by DdERK2. While expression of wild-type EppA in wild-type cells had no effect on any of the phenotypes we have measured, expression of the S250A mutant of EppA in wild-type cells (S250A/EppA) caused a delay in development, consistent with phosphorylation of EppA being important for signaling during development. When we looked at chemotaxis and signal relay, EppA/S250A cells showed decreased directionality, velocity, and persistence in cAMP gradients and lower intracellular cAMP accumulation. These data suggest that the S250A mutant may be a dominant-negative form of EppA, raising the possibility that EppA forms a complex with downstream components that is altered by phosphorylation of EppA.
The precise mechanism(s) by which EppA regulates cAMP
synthesis and chemotaxis is still unclear. With respect to cAMP
synthesis, EppA may act directly on RegA or in parallel. Although RegA
has a potential phosphorylation site (threonine 676) and mutation of
the threonine impairs DdERK2-dependent inhibition of RegA
(16), there is no direct
evidence that RegA is phosphorylated at that site. Thus, it is formally
possible that ERK2 phosphorylates EppA and EppA regulates inhibition of
RegA in cAMP-stimulated cells. Alternatively, EppA may act in parallel
with RegA to control cyclase activity. The regulatory mechanism of ACA
activity is complex (22).
It is known that CRAC (cytosolic regulator of adenylyl cyclase)
(5,
6,
25), RasC
(12), Rip3
(10), RasGEF
(9), and Pia
(4) are required for
activation of ACA. How these proteins interact with each other and ACA
is unclear. For the adaptation of ACA, G
9 was found to have an
inhibitory effect on ACA
(3). Since
G
9-null cells still showed periodic signaling, there must be
other mechanisms to negatively regulate ACA.
With respect to the reduction in chemotaxis, the defects in EppA disruptants may be due to the alteration in intracellular cAMP. Proper accumulation and degradation of cAMP is important for protein kinase A function and inhibition of lateral pseudopod formation in chemotaxis (29). Mutants lacking ACA have reduced chemotactic responses in cAMP gradients, and thus, the reduced cAMP production in eppA cells could result in a phenotype similar to that of aca mutants.
The sequence of EppA does not show strong homologies to other proteins, as is also true for CRAC, another regulator of adenylyl cyclase (11). The presence of strings of arginines and a repeated motif involving glycine can be seen in DNA and RNA binding proteins, but sequence searches have not identified a standard DNA or RNA binding domain. Thus, it is possible that EppA is also involved in regulation of transcription or translation. The glycine-rich domain of TAFII68 has been shown to interact with the DNA binding domain in cis or in trans (1), and thus, EppA's glycine-rich domain may also play a role in intramolecular or intermolecular interactions. The myc-tagged EppA construct, which fully restores chemotaxis and development in the EppA disruptants, is mainly cytoplasmic and not localized to the nucleus. Thus, we currently favor models focusing on a cytoplasmic function for EppA.
In summary, we have identified a novel protein, EppA, whose phosphorylation is regulated by DdERK2 and which is necessary for chemotaxis to cAMP and intracellular production of cAMP. We have identified the DdERK2-dependent phosphorylation site on EppA and shown that mutating this site to alanine generates a dominant-negative form, demonstrating that phosphorylation is important in the regulation of EppA. Identification of the interacting partners of EppA will aid in determining the mechanism of action of EppA in the regulation of cAMP production and chemotaxis.
BglII plasmid, and H. Urushihara and the Japanese
Dictyostelium cDNA project for providing the full-length cDNA
of EppA. We also thank R. Angeletti and E. Neives for help on MALDI-TOF
analysis and J. Chubb for help on establishing knockout
strains. We appreciate the suggestion of EppA as the name for p45 from
a reviewer. This work was supported by MCB9728324 and CA100324.
|
|
|---|
-mediated inhibition of developmental
signal response. Curr. Biol.
12:1199-1208.[CrossRef][Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»